He will compare the results from ROP animals with that from healthy animals to check how ROP damages the retina. They will also calculate several indicators to evaluate the degree of difference in retina. The evidence and results will cast new insight of doctors’ clinic practice for ROP.
Read MoreThe KTEF grant allowed ARVO to award an additional 95 travel grants in 2022, an increase of nearly 21%, for a total of nearly 462 grants for the year. For more than half a century, the KTEF has funded research grants with the goal of improving and preserving vision. As our Foundation has grown since its inception in 1955, it has expanded the number and size of grants and has commenced new initiatives in ophthalmology research and education. The Foundation’s research grants are targeted to new research by those in the early stages of their careers.
Read MoreThis novel biomedical research is the first step to develop disease-specific, minimally invasive methods for clinical diagnostics using EVs with improved understating of the applications of AH liquid biopsy as well as future development of new therapeutic approaches.
Read MoreAt the 2022 Grand Commandery of California Annual Conclave a Sword of Merit was presented by SK David Kussman, Grand Master of the Grand Encampment Knights Templar; SK Jeffrey Bolstad, Deputy Grand Master of the Grand Encampment Knights Templar to the outgoing Grand Commander; SK David Studley who is also the Grand Captain General of the Grand Encampment Knights Templar. All three are also Officers and Trustees of the Knights Templar Eye Foundation.
Read MoreThe 54th Annual Voluntary Campaign Final Report is now available for review.
Read MoreThe Officers and Trustees of the Knights Templar Eye Foundation wish to thank all Grand Commanderies that have become either 100% or 200% Life Sponsors within their jurisdiction and also to those Grand Commanderies that are activity working towards the 100% goal.
Read MoreTwo Golden Chalice presentations were made in the Grand Commandery of the Knights Templar of Pennsylvania within Pittsburgh Commandery No. 1 and Duquesne Commandery No. 72.
Read MoreThis Sword was in recognition of SK Rossman’s donating to the Grand Masters Club completing Tier 5 with a total of 25 Grand Masters Clubs totaling $25,000 in contributions. In reaching 25 Grand Masters Clubs the Knights Templar Eye Foundation automatically recognizes this great accomplishment by awarding a Sword of Merit. SK Rossman donated an additional $10,000 contribution for the Golden Chalice which was to honor his wife.
Read MoreIn a cohort of COD/CRD patients, they will combine the cutting-edge short and long-read wholegenome sequencing to investigate the noncoding and structural genetic variants, which are both often missed by current Sanger sequencing and capture-sequencing technologies. The genetic testing pipeline which will be built in this study may also be used to study other genetic diseases in the future.
Read MoreOn April 4, 2022, SK David Studley, Grand Captain General of The Grand Encampment who is also the Grand Commander of California, and Trustee of the Knights Templar Eye Foundation presented a Sword of Merit on behalf of the Knights Templar Eye Foundation during a reception honoring SK Studley at Marysville Commandery No. 7, receiving the sword was SK Stephan Parnow, Commander of Marysville Commandery.
Read MoreOur meeting ended with twenty-two Competitive Renewal & Career Starter grants for a total of $1,533,025 that were recommended by the SAC doctors and later that night approved by the KTEF SAC committee.
Read MoreThe significance of this scientific direction is highlighted by the fact that numerous blindness-causing mutations, in addition to those in PRCD, that affect children are associated with accumulation of extracellular vesicles in the retina. Therefore, addressing the cellular and molecular mechanisms underlying their formation and clearance are key steps in developing future therapeutic strategies.
Read MoreChildhood glaucoma is a pediatric condition leading to significant visual impairment. Juvenile-onset primary open angle glaucoma (JOAG) is a subtype of primary glaucoma, and the disease presents from four years to early adulthood. The disease is identified by increased pressure within the eye and progressive death of neurons in the back of the eye, which can eventually lead to blindness in children.
Read MoreThe fovea is a specialized retinal area that enables high-acuity vision, and we use it to detect fine spatial details and colors. In mammals, only humans and some primates have a fovea, but we know relatively little about how the fovea is formed.
Read MoreBy studying these changes over time with and without the drug, we will begin to understand the cellular and metabolic mechanisms responsible for this devastating group of diseases that cause childhood blindness. These studies will move us closer to developing a novel drug capable of treating vision loss in this diverse set of inherited diseases regardless of gene mutation.
Read MoreOn January 12, 2022, SK Michael Daniels, Right Eminent Past Grand Commander of the Grand Commandery of North Carolina presented a Sword of Merit on behalf of the Knights Templar Eye Foundation during the stated meeting of Nazareth Commandery No. 41 to SK D. Trent Carter, Eminent Commander of Nazareth Commandery
Read MoreIt is with great sadness that we announce the passing of Most Eminent Past Grand Master William Jackson Jones, GCT, on January 31, 2022. He was a true Masonic Christian Gentleman who will be greatly missed by his family, Masonic and Templar family, dental patients, and community.
Read MoreOver the last year, Dr. Meier has successfully developed a way of quickly measuring the specific neural deficits that underlies an individual’s poor vision. She plans to use this same task in children, while recording brain responses over time. Her long-term aim is to develop a way of measuring brain responses in young pre-verbal children. Once they know a child’s specific neural deficits, clinicians can generate individualized treatments that target his or her specific pattern of neural abnormalities – resulting in faster and better treatment.
Read MoreThe proposed study presents a unique opportunity to gain new insights into the establishment of a functional retinal network but also identify new regulatory signaling events allowing us to modulate blood vessel growth essential for alternative therapies such as ROP. 3
Read MoreUnderstanding this causal sequence is critical to developing treatments that address the cause(s) of juvenile myopia, not just the symptoms as current treatments do. This is extremely important because myopia is estimated to affect 30% of the world’s population already (the cost in the US alone being $4 billion a year) and will affect 50% of the world’s population by 2050.
Read More
